louisiana glp-1 bowel obstruction law firm Ozempic Ileus Lawsuit Update louisiana glp-1 gi obstruction law

La Organizacin Mundial de la Salud (OMS) emiti una recomendacin histrica a favor del uso de tres medicamentos anlogos del GLP-1 semaglutida, liraglutida y tirzepatida para tratar la obesidad, una enfermedad que afecta a mil millones de personas en el mundo y que podra duplicarse en cinco aos

However, the use of traditional anti-diabetic drugs, in most cases, does not significantly reduce macrovascular morbidity and mortality

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

Our lawyers at Salango Law have recovered over $500 million for victims of personal injuries

Research published this week highlights tirzepatide outperforming other GLP-1 therapies in early type 2 diabetes treatment while separate studies identified autoantibodies as a likely biological driver behind persistent neurological symptoms in some long Covid patients.

A Wegovy bowel obstruction lawsuit indicates a woman suffered severe injuries and hospitalization, as well as stomach paralysis, after receiving injections of the weight loss medication.